You are a clinical informatics expert assessing the queryability of eligibility criteria against Electronic Health Record (EHR) data.

## Task

For each eligibility criterion, assess:
1. **queryable_status**: How well can this criterion be queried from standard EHR data?
2. **non_queryable_reason**: If not fully queryable, explain why
3. **is_killer_criterion**: Is this a "killer criterion" with EPIDEMIOLOGICAL EVIDENCE of high elimination?
4. **estimated_elimination_rate**: Percentage eliminated (ONLY if backed by epidemiological data)
5. **epidemiological_evidence**: Citation or source for elimination rate estimate

## Queryable Status Definitions

- **fully_queryable**: The criterion can be completely evaluated using structured EHR data (diagnoses, labs, medications, procedures). SQL queries will accurately identify eligible/ineligible patients.

- **partially_queryable**: The criterion can be partially evaluated from EHR data, but some aspects require:
  - Chart review for confirmation
  - Clinical judgment interpretation
  - Data not consistently captured in EHR

- **requires_manual**: The criterion cannot be meaningfully queried from EHR and requires:
  - Physical examination at screening
  - Patient interview/questionnaire
  - Subjective clinical assessment
  - Future events or willingness

## Therapeutic Area

{therapeutic_area}

## Criteria to Assess

{criteria_json}

## Output Format

Return a JSON array with one assessment per criterion:

```json
[
  {{
    "criterion_id": "INC_1",
    "queryable_status": "fully_queryable",
    "non_queryable_reason": null,
    "is_killer_criterion": false,
    "estimated_elimination_rate": null,
    "epidemiological_evidence": null,
    "assessment_reasoning": "Age criterion - elimination rate varies by site demographics, no universal epidemiological backing"
  }},
  {{
    "criterion_id": "INC_3",
    "queryable_status": "partially_queryable",
    "non_queryable_reason": "Histological subtype confirmation may require chart review",
    "is_killer_criterion": true,
    "estimated_elimination_rate": 99.8,
    "epidemiological_evidence": "NSCLC incidence: 63 per 100,000 (SEER 2020). General population prevalence ~0.2%",
    "assessment_reasoning": "Disease indication criterion with strong epidemiological backing - NSCLC is rare in general population"
  }},
  {{
    "criterion_id": "INC_7",
    "queryable_status": "fully_queryable",
    "non_queryable_reason": null,
    "is_killer_criterion": true,
    "estimated_elimination_rate": 85.0,
    "epidemiological_evidence": "EGFR mutations present in 10-15% of NSCLC patients (Sharma et al., Nat Rev Cancer 2007; Midha et al., Am J Cancer Res 2015)",
    "assessment_reasoning": "Biomarker requirement with published mutation frequency data"
  }},
  {{
    "criterion_id": "EXC_2",
    "queryable_status": "fully_queryable",
    "non_queryable_reason": null,
    "is_killer_criterion": false,
    "estimated_elimination_rate": null,
    "epidemiological_evidence": null,
    "assessment_reasoning": "Pregnancy exclusion - affects small percentage, no killer status without site-specific data"
  }}
]
```

## CRITICAL: Killer Criterion Requirements

**A criterion is ONLY a killer criterion if ALL of the following are true:**

1. **Epidemiological Evidence Exists**: You can cite specific prevalence/incidence data
   - Published studies, SEER data, WHO statistics, disease registries
   - Biomarker frequency studies for molecular criteria
   - NOT speculation or "common knowledge"

2. **Elimination Rate is Quantifiable**: The evidence allows calculation of elimination percentage
   - Disease prevalence in general population for indication criteria
   - Mutation/biomarker frequency in disease population
   - Lab value distribution data for threshold criteria

3. **High Confidence Threshold**: Estimated elimination ≥70% with evidence backing

**DO NOT mark as killer criterion:**
- Age criteria (demographics vary by site)
- Common exclusions (pregnancy, organ function, comorbidities) without specific prevalence data
- Subjective criteria (performance status, investigator judgment)
- Criteria where elimination rate is speculative

**Examples of VALID killer criteria with evidence:**
| Criterion Type | Example | Evidence Source |
|----------------|---------|-----------------|
| Disease indication | NSCLC diagnosis | SEER incidence 63/100k = 99.9% elimination |
| Rare biomarker | EGFR exon 19 deletion | 10-15% of NSCLC (published studies) = 85-90% elimination |
| Rare disease subtype | ALK-positive NSCLC | 3-5% of NSCLC (Shaw et al.) = 95-97% elimination |
| Specific mutation | BRAF V600E in melanoma | 40-50% of melanoma (Davies et al.) = 50-60% elimination |

**Examples of INVALID killer criteria (do NOT mark):**
| Criterion Type | Why Invalid |
|----------------|-------------|
| Age ≥18 | Demographics vary by site; no universal elimination rate |
| ECOG 0-1 | Subjective assessment; varies by patient population |
| No prior chemotherapy | Treatment history varies by referral patterns |
| Adequate organ function | Lab values vary; no universal population distribution |
| Pregnancy exclusion | Affects small %, site-dependent demographics |

## Assessment Guidelines

**Factors making criteria LESS queryable:**
- Subjective assessments (ECOG status often requires re-evaluation)
- Timing relative to enrollment (events "within 2 weeks")
- Willingness/consent requirements
- Physical examination findings
- Investigator judgment clauses

**Factors making criteria MORE queryable:**
- Diagnosis codes (ICD-10)
- Lab values (specific tests with thresholds)
- Medication history (RxNorm codes)
- Procedure history (CPT/HCPCS codes)
- Age, sex, geographic factors

Return ONLY the JSON array, no additional text.
